Key result
Female sex shows no excess long-term mortality risk compared to males after MIDCAB.
Why the study?
Does female sex confer a higher risk of adverse outcomes and long-term mortality compared to male sex in patients undergoing minimally invasive direct CABG?
Population
350 consecutive patients with single-vessel and LAD-predominant coronary artery disease undergoing minimally…
Comparison
Female sex (undergoing MIDCAB) vs Male sex
Design
Cohort
Follow-up
median 19.0 years (IQR 11.8–23.9)
Authors
Loading...
Supports MIDCAB as sex-neutral in single-vessel disease; extends observational data but leaves randomized confirmation open.
Cohort (n=350)
No
Does female sex confer a higher risk of adverse outcomes and long-term mortality compared to male sex in patients undergoing minimally invasive direct CABG?
Hazard Ratio: 0.8 (95% CI 0.38–1.7)
Absolute Event Rate: 12% vs 12%
p-value: p=0.560
In patients undergoing minimally invasive direct CABG for single-vessel disease, female sex is not associated with worse perioperative safety or long-term survival compared to men, supporting MIDCAB as a sex-neutral revascularization strategy.
Amanov et al. (2026) conducted a cohort in Single-vessel coronary artery disease (n=350). Female sex vs. Male sex was evaluated on all-cause long-term mortality (HR 0.80, 95% CI 0.38-1.70, p=0.560). Female sex was not associated with increased long-term all-cause mortality after MIDCAB compared to males (12.0% vs 12.0%; adjusted HR 0.80, 95% CI 0.38-1.70, p=0.560).
Synapse has enriched one closely related paper. Consider it for comparative context: